Get the Stockscreener App
58.57
2.24%
1.36
Centene Corp stock is traded at $58.57, with a volume of 1.82M.
It is up +2.24% in the last 24 hours and up +34.46% over the past month.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
See More
Previous Close:
$57.21
Open:
$58.09
24h Volume:
1.82M
Relative Volume:
0.29
Market Cap:
$28.93B
Revenue:
$198.10B
Net Income/Loss:
$-6.45B
P/E Ratio:
-4.4559
EPS:
-13.1443
Net Cash Flow:
$7.11B
1W Performance:
+0.36%
1M Performance:
+34.46%
6M Performance:
+48.23%
1Y Performance:
+1.46%
1-Day Range:
$57.78
$58.68
1-Week Range:
$56.74
$59.23
52-Week Range:
$25.07
$60.76
Centene Corp Stock (CNC) Company Profile
Name
Centene Corp
Sector
Industry
Phone
(314) 725-4477
Address
7700 FORSYTH BLVD., ST LOUIS
Compare CNC vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
58.58 | 28.25B | 198.10B | -6.45B | 7.11B | -13.14 |
UNH
Unitedhealth Group Inc
|
382.12 | 342.24B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
91.87 | 115.76B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
388.68 | 84.23B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
284.52 | 74.29B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
305.69 | 36.22B | 137.20B | 1.15B | 1.27B | 9.3439 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-14-25 | Initiated | Goldman | Sell |
| Jul-28-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-23-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Jul-16-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-10-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-02-25 | Downgrade | UBS | Buy → Neutral |
| Jun-09-25 | Resumed | Morgan Stanley | Overweight |
| Jun-02-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-08-25 | Upgrade | Jefferies | Underperform → Hold |
| Feb-06-25 | Downgrade | Argus | Buy → Hold |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Dec-13-24 | Upgrade | UBS | Neutral → Buy |
| Dec-10-24 | Downgrade | Jefferies | Hold → Underperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Mar-21-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-20-23 | Initiated | UBS | Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-30-22 | Initiated | Argus | Buy |
| Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-28-22 | Resumed | Barclays | Overweight |
| Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Resumed | Bernstein | Outperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-07-22 | Resumed | Barclays | Overweight |
| Jan-06-22 | Resumed | JP Morgan | Overweight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
| Dec-13-21 | Reiterated | BofA Securities | Buy |
| Dec-13-21 | Reiterated | Credit Suisse | Neutral |
| Dec-13-21 | Reiterated | Mizuho | Neutral |
| Dec-13-21 | Reiterated | Oppenheimer | Outperform |
| Dec-13-21 | Reiterated | Stephens | Overweight |
| Dec-13-21 | Reiterated | Truist | Buy |
| Dec-13-21 | Reiterated | Wells Fargo | Overweight |
| Dec-13-21 | Reiterated | Wolfe Research | Outperform |
| Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-19-21 | Initiated | Wells Fargo | Overweight |
| May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-10-21 | Initiated | Mizuho | Neutral |
| Jan-21-21 | Resumed | Goldman | Neutral |
| Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-03-20 | Resumed | Evercore ISI | Outperform |
| Jan-28-20 | Reiterated | Bernstein | Outperform |
| Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| May-10-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Jul-18-18 | Resumed | Citigroup | Neutral |
| Dec-18-17 | Reiterated | Jefferies | Buy |
| Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
| Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-17 | Reiterated | Barclays | Overweight |
| Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
| Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp Stock (CNC) Latest News
Centene Corp. stock (US15133V1035): earnings beat and service award put Medicaid specialist in focus - AD HOC NEWS
Is Centene Corp (CNC) a Bargain After 3.3% Drop? GF Value Says U - GuruFocus
Centene Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
CNC Maintains Overweight Rating by Barclays -- Price Target Rais - GuruFocus
Centene Corp. stock (US15133V1035): Medicaid specialist tightens 2026 outlook after strong quarter - AD HOC NEWS
Centene Analyst Ratings and Price Targets | NYSE:CNC - Benzinga
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
CNCCentene Corp Stock Price and Quote - Finviz
CNC Maintained by UBS -- Price Target Raised to $61.00 - GuruFocus
This Summit Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For FridayCentene (NY - Benzinga
This Q32 Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday - Benzinga
CNC News | CENTENE CORP (NYSE:CNC) - ChartMill
Centene stock (US15133V1035): Bank of America lifts target as managed-care outlook shifts - AD HOC NEWS
Centene stock (US15133V1035): Bank of America lifts target as managed-care outlook improves - AD HOC NEWS
CNC Stock Quote Price and Forecast - CNN
CNC Maintained by B of A Securities -- Price Target Raised to $7 - GuruFocus
Centene’s SWOT analysis: managed care stock faces enrollment headwinds - Investing.com
Centene Corp. stock (US15133V1035): Mizuho lifts target as investors weigh managed-care outlook - AD HOC NEWS
How New Medicaid and Medicare Leadership at Centene (CNC) Has Changed Its Investment Story - simplywall.st
Centene Corp. stock outperforms competitors despite losses on the day - MarketWatch
CNC Maintained by Mizuho -- Price Target Raised to $58 - GuruFocus
Deutsche Bank upgrades Centene stock rating on earnings recovery - Investing.com
Deutsche Bank upgrades Centene stock rating on earnings recovery By Investing.com - Investing.com Canada
Deutsche Bank upgrades Centene (CNC) - MSN
Centene Corp. stock (US15133V1035): Q1 2026 earnings highlight medical cost trends - AD HOC NEWS
Centene Corp. stock (US15133V1035): Q1 2026 earnings highlight scale and cost focus - AD HOC NEWS
Centene Corp. stock (US15133V1035): first-quarter 2026 results put medical costs and margins in focu - AD HOC NEWS
Why Is Centene Stock Trending Across Healthcare - Kalkine Media
CNC Stock Price, Quote & Chart | CENTENE CORP (NYSE:CNC) - ChartMill
Centene stock (US15133V1035): Health insurer faces renewed scrutiny after first-quarter 2026 results - AD HOC NEWS
Centene Corporation (CNC) Announces Key Executive Appointments a - GuruFocus
Centene stock (US15133V1035): Earnings, Medicaid dynamics and outlook for US healthcare investors - AD HOC NEWS
Centene (CNC) price target increased by 23.07% to 57.73 - MSN
Centene Corp stock (US15133V1035): 6% surge to $59.31 - AD HOC NEWS
Easing medical costs a positive for health insurers, but real test lies ahead, analysts say - Reuters
Centene Corp stock (US15133V1035): Shares surge 6% to $59.31 - AD HOC NEWS
Centene Corp stock (US15133V1035): 6% surge to $59.31 on May 12 - AD HOC NEWS
1CNC.MI Technical Analysis | Trend, Signals & Chart Patterns | CENTENE CORP (BIT:1CNC) - ChartMill
A Look at Centene Corp (CNC) After 6.0% Gain -- GF Value $84.31 vs Price $59.31 - GuruFocus
Is Centene Corporation (CNC) One of the Best Healthcare Stocks to Buy for the Long Term? - Insider Monkey
Acadia Healthcare, Centene long picks by Greenlight's Einhorn at Sohn conf (ACHC:NASDAQ) - Seeking Alpha
Coordinated Care and Seattle Seahawks Host Youth Mental Health Summit – Company Announcement - Financial Times
10 Health Care Stocks Whale Activity In Today's Session - Benzinga
Centene Corp stock (US15133V1035): Q1 2026 earnings show $3.11 GAAP EPS - AD HOC NEWS
5 Best Healthcare Stocks to Buy for the Long Term - Insider Monkey
Centene Corp. stock (US15133V1035): Analysts lift price targets amid Medicaid headwinds and margin r - AD HOC NEWS
Centene Corp (CNC) Stock Price, Quote, News & History - Benzinga
ACA enrollment losses reshape insurers’ 2026 outlook - Modern Healthcare
Has Centene (CNC) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Is Wall Street Bullish or Bearish on Centene Stock? - Barchart.com
Centene (CNC) tops Q1 earnings and revenue estimates - MSN
Centene Corp Stock (CNC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.60%
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):